Status:

RECRUITING

Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Clinical High Risk for Psychosis (CHR)

Eligibility:

All Genders

14-25 years

Phase:

NA

Brief Summary

This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis typically emerges during late adolescence...

Detailed Description

Psychosis typically emerges in late adolescence or early adulthood, which is a vital stage in social and cognitive development, and can therefore have a profoundly adverse impact on an individual's lo...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age 14-25
  • Ability to participate in assessments and treatment in English
  • Meets criteria for psychosis-risk on SIPS
  • Stable on medications; no changes within 1 month prior to enrollment
  • Identification of one "family member" with \>4 hours/week contact who is willing to participate ("Family member" can be any blood relative, spouse, significant other, or close friend whom the subject identifies as a consistent and important person in their life).
  • Exclusion criteria:
  • Intellectual disability (IQ\<70)
  • Medical condition known to cause psychosis
  • Moderate or severe substance use disorder and active use within the past 30 days.

Exclusion

    Key Trial Info

    Start Date :

    July 21 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2025

    Estimated Enrollment :

    72 Patients enrolled

    Trial Details

    Trial ID

    NCT05968560

    Start Date

    July 21 2023

    End Date

    December 31 2025

    Last Update

    July 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Icahn School of Medicine at Mount Sinai

    New York, New York, United States, 10029